Jyong Biotech MENS
NASDAQ MENS
$2.05 +0.02 (+0.99%)
At close: Sep 30, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Operating Leases (2024 - 2025)

Updated

Jyong Biotech's Operating Leases came in at $68,000 for the quarter ended Dec 31, 2025, up 65.9% from $41,000 a year earlier.

Analysis

Jyong Biotech (MENS) Operating Leases (2024 - 2025) Analysis & Trends

  • Going back by year, Operating Leases was $41,000 in the year ended Dec 31, 2024 (+141.2%) and $17,000 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Jyong Biotech 155.86 Mn 155.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 68,000.00
Jun 30, 2025 59,000.00
Dec 31, 2024 41,000.00
API Access

Jyong Biotech Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=MENS&period=max&api_key=YOUR_API_KEY